Literature DB >> 18057236

Functional analysis of the murine cytomegalovirus chemokine receptor homologue M33: ablation of constitutive signaling is associated with an attenuated phenotype in vivo.

Ruth Case1, Emma Sharp, Tau Benned-Jensen, Mette M Rosenkilde, Nicholas Davis-Poynter, Helen E Farrell.   

Abstract

The murine cytomegalovirus (MCMV) M33 gene is conserved among all betaherpesviruses and encodes a homologue of seven-transmembrane receptors (7TMR) with the capacity for constitutive signaling. Previous studies have demonstrated that M33 is important for MCMV dissemination to or replication within the salivary glands. In this study, we probed N- and C-terminal regions of M33 as well as known 7TMR signature motifs in transmembrane (TM) II and TM III to determine the impact on cell surface expression, constitutive signaling, and in vivo phenotype. The region between amino acids R(340) and A(353) of the C terminus was found to be important for CREB- and NFAT-mediated signaling, although not essential for phosphatidylinositol turnover. Tagging or truncation of the N terminus of M33 resulted in loss of cell surface expression. Within TM II, an F79D mutation abolished constitutive signaling, demonstrating a role, as in other cellular and viral 7TMR, of TM II in receptor activation. In TM III, the arginine (but not the asparagine) residue of the NRY motif (the counterpart of the common DRY motif in cellular 7TMR) was found to be essential for constitutive signaling. Selected mutations incorporated into recombinant MCMV showed that disruption of constitutive signaling for a viral 7TMR homologue resulted in a reduced capacity to disseminate to or replicate in the salivary glands. In addition, HCMV UL33 was found to partially compensate for the lack of M33 in vivo, suggesting conserved biological roles of the UL33 gene family.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18057236      PMCID: PMC2258698          DOI: 10.1128/JVI.02550-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor.

Authors:  M Burger; J A Burger; R C Hoch; Z Oades; H Takamori; I U Schraufstatter
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

2.  Conserved polar residues in the transmembrane domain of the human tachykinin NK2 receptor: functional roles and structural implications.

Authors:  D Donnelly; S Maudsley; J P Gent; R N Moser; C R Hurrell; J B Findlay
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

Review 3.  Cytomegalovirus-encoded homologs of G protein-coupled receptors and chemokines.

Authors:  Koen W R van Cleef; Martine J Smit; Cathrien A Bruggeman; Cornelis Vink
Journal:  J Clin Virol       Date:  2006-01-06       Impact factor: 3.168

4.  The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities.

Authors:  D Morin; N Cotte; M N Balestre; B Mouillac; M Manning; C Breton; C Barberis
Journal:  FEBS Lett       Date:  1998-12-28       Impact factor: 4.124

Review 5.  Molecular basis of receptor/G-protein-coupling selectivity.

Authors:  J Wess
Journal:  Pharmacol Ther       Date:  1998-12       Impact factor: 12.310

6.  Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6.

Authors:  S G Rasmussen; A D Jensen; G Liapakis; P Ghanouni; J A Javitch; U Gether
Journal:  Mol Pharmacol       Date:  1999-07       Impact factor: 4.436

Review 7.  HCMV-encoded G-protein-coupled receptors as constitutively active modulators of cellular signaling networks.

Authors:  Henry F Vischer; Rob Leurs; Martine J Smit
Journal:  Trends Pharmacol Sci       Date:  2005-12-13       Impact factor: 14.819

8.  Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33.

Authors:  Daniel N Streblow; Craig N Kreklywich; Patricia Smith; Jordana L Soule; Christine Meyer; Michael Yin; Patrick Beisser; Cornelis Vink; Jay A Nelson; Susan L Orloff
Journal:  Am J Transplant       Date:  2005-03       Impact factor: 8.086

9.  Human cytomegalovirus subverts the functions of monocytes, impairing chemokine-mediated migration and leukocyte recruitment.

Authors:  Giada Frascaroli; Stefania Varani; Barbara Moepps; Christian Sinzger; Maria Paola Landini; Thomas Mertens
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

10.  Summary of the II International Symposium on Cytomegalovirus.

Authors:  M D de Jong; G J Galasso; B Gazzard; P D Griffiths; D A Jabs; E R Kern; S A Spector
Journal:  Antiviral Res       Date:  1998-10       Impact factor: 5.970

View more
  26 in total

1.  Partial functional complementation between human and mouse cytomegalovirus chemokine receptor homologues.

Authors:  Helen E Farrell; Alexander M Abraham; Rhonda D Cardin; Alexander H Sparre-Ulrich; Mette M Rosenkilde; Katja Spiess; Tine H Jensen; Thomas N Kledal; Nicholas Davis-Poynter
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

2.  Methods for Studying the Function of Cytomegalovirus GPCRs.

Authors:  Christine M O'Connor; William E Miller
Journal:  Methods Mol Biol       Date:  2021

3.  Identification of common mechanisms by which human and mouse cytomegalovirus seven-transmembrane receptor homologues contribute to in vivo phenotypes in a mouse model.

Authors:  Helen E Farrell; Alexander M Abraham; Rhonda D Cardin; Ann-Sofie Mølleskov-Jensen; Mette M Rosenkilde; Nicholas Davis-Poynter
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

Review 4.  Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases?

Authors:  Henry F Vischer; Marco Siderius; Rob Leurs; Martine J Smit
Journal:  Nat Rev Drug Discov       Date:  2014-01-21       Impact factor: 84.694

5.  The human cytomegalovirus-encoded G protein-coupled receptor UL33 exhibits oncomodulatory properties.

Authors:  Jeffrey R van Senten; Maarten P Bebelman; Tian Shu Fan; Raimond Heukers; Nick D Bergkamp; Puck van Gasselt; Ellen V Langemeijer; Erik Slinger; Tonny Lagerweij; Afsar Rahbar; Marijke Stigter-van Walsum; David Maussang; Rob Leurs; René J P Musters; Guus A M S van Dongen; Cecilia Söderberg-Nauclér; Thomas Würdinger; Marco Siderius; Martine J Smit
Journal:  J Biol Chem       Date:  2019-09-13       Impact factor: 5.157

6.  The carboxy-terminal tail of human cytomegalovirus (HCMV) US28 regulates both chemokine-independent and chemokine-dependent signaling in HCMV-infected cells.

Authors:  Melissa P Stropes; Olivia D Schneider; William A Zagorski; Jeanette L C Miller; William E Miller
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

Review 7.  Autoimmunity and infection in Sjögren's syndrome.

Authors:  Ann Igoe; R Hal Scofield
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

8.  Activation of intracellular signaling pathways by the murine cytomegalovirus G protein-coupled receptor M33 occurs via PLC-{beta}/PKC-dependent and -independent mechanisms.

Authors:  Joseph D Sherrill; Melissa P Stropes; Olivia D Schneider; Diana E Koch; Fabiola M Bittencourt; Jeanette L C Miller; William E Miller
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

9.  The M33 G protein-coupled receptor encoded by murine cytomegalovirus is dispensable for hematogenous dissemination but is required for growth within the salivary gland.

Authors:  Fabiola M Bittencourt; Shu-En Wu; James P Bridges; William E Miller
Journal:  J Virol       Date:  2014-08-06       Impact factor: 5.103

10.  The M33 chemokine receptor homolog of murine cytomegalovirus exhibits a differential tissue-specific role during in vivo replication and latency.

Authors:  Rhonda D Cardin; Gregory C Schaefer; Janelle R Allen; Nicholas J Davis-Poynter; Helen E Farrell
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.